Steris reported $319.2M in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
3M USD 1.56B 57M Sep/2026
Accuray USD 11.38M 12.71M Sep/2024
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Boston Scientific USD 1.01B 232M Sep/2026
CONMED USD 37.14M 739K Sep/2026
Cooper Companies USD 222M 253M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Ecolab USD 891.9M 82.9M Sep/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Fortive USD 235.9M 26M Sep/2026
Getinge SEK 1.35B 669M Jun/2026
Globus Medical USD 178.23M 224.2M Sep/2026
Haemonetics USD 75.12M 17.66M Sep/2026
Idexx Laboratories USD 402.35M 23.22M Sep/2026
Insulet USD 189.8M 60.1M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
J&J USD 6.47B 1B Sep/2026
Olympus JPY 55.89B 25.82B Sep/2026
Orthofix International USD 6.12M 1.91M Dec/2025
Owens Minor USD 814K 28.08M Dec/2025
ResMed USD 454.34M 51.33M Jun/2026
Steris USD 319.2M 33.4M Sep/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -2.37M 11.42M Sep/2026
Teleflex USD -105.77M 178.84M Sep/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Zimmer Biomet Holdings USD 341.5M 3.2M Sep/2026